oral semaglutide review vs injection efficacy Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist with Both Injectable and Formulations TrimRX Choosing Oral vs. Injectable Semaglutide

Always use a new needle: It minimizes the risk of contamination and blockage when reusing needles

Disclaimer: Always consult a licensed healthcare provider to determine if a GLP-1 medication is appropriate for your health profile

Phase 3 TRIUMPH Program (Ongoing) - LIVER AS SECONDARY ENDPOINT Status: Currently ongoing, results expected 2026 TRIUMPH-4 (Completed December 2025): Primary endpoints: Weight loss + osteoarthritis pain Results: 28.7% weight loss at 68 weeks Liver outcomes: Secondary/exploratory endpoints TRIUMPH-2 (Ongoing, expected 2026): Weight loss in obesity + type 2 diabetes Liver outcomes: Secondary endpoints (liver enzymes, possibly imaging) Key Point: TRIUMPH Phase 3 trials are NOT primarily liver-focused

Major US medical organizations including ACOG, The Menopause Society, and NASEM have concluded that claims describing compounded bioidentical hormone therapy as safer or more effective than FDA-approved hormone therapy are not substantiated by evidence from well-designed clinical studies

This allows us to investigate the homeostatic mechanisms that protect the system against fluctuations in the inputs

doi: 10.1016/j.jaad.2025.06.022